//
Get monthly newsletter intelligence — trends, top movers, new opportunities
Newsletter Insights — advertising rates and audience data for 45K+ newsletters
Browse all →Advertisers are viewing this page. Claim it
Track COVID Intel - by William Makis (McGill Medicine)'s growth
Get notified when subscribers, engagement, or pricing changes
Platform Portability
Uses Substack subdomain (makisw.substack.com). Migrating would require subscribers to re-subscribe at a new address.
Custom domains let newsletters switch platforms without losing their audience.
Are you a newsletter creator? Get verified insights →
Cutting Edge Cancer Research, Repurposed Drugs in Cancer, Ivermectin, Mebendazole, Fenbendazole. Content is for informational purposes only. Entirely donation based. None of the information constitutes medical advice (see your doctor as needed).
Data updated 3 days ago
Avg Comments
33.0
Avg Likes
156.9
Engagement Rate
0.13%· ~190 likes + comments/post
(comments + likes) / subscribers
Typical for lists with 147K+ subscribers
Quality Score
Engagement vs Health
0.13% engagement rate
Score Breakdown
Engagement Score
| Subscriber-only |
| IVERMECTIN, FENBENDAZOLE, MCP, CBD Testimonial - 62 year old Switzerland man with Prostate Cancer Gleason 6, PSA 9.27 reports after 3.5 months: PSA dropped 9.27 to 4.88!Aug 26, 2026 | Subscriber-only |
| IVERMECTIN and FENBENDAZOLE Testimonial - 67 year old New York man with Bladder Cancer Urothelial High Grade reports after 8 months: Cancer FreeAug 25, 2026 | Subscriber-only |
| FENBENDAZOLE SALE - BP Life has sale on 1kg of Fenbendazole powder!WEBSITE LINK (CODE: MAKIS15)Aug 22, 2026 | Public |
| NEW IVERMECTIN TABLETS from All Family Pharmacy in Boca Raton Florida!New Ivermectin Tablets Are Now Available!Aug 22, 2026 | Public |
vs 130 newsletters in Health
147K places you in the top 10% of newsletters in this category.
Engagement Rate
0.13%
median: 0.00%
Posts per Week
13.0
median: 1.0
Publishing Consistency
96/100
median: 67/100
Subscribers
147K
median: 1K
Here's what we know about this newsletter's activity:
Publishing Pace
Daily
Very Consistent
Category Rank
#8 of 754
in Health
Engagement Trend
Rising
based on recent posts
8.7K paid
Paid Subscriber Retention
+0.7%
net growth
Track revenue changes over time
Start tracking — freeTrack CPM rates as they change
Start tracking — freeCOVID Intel - by William Makis (McGill Medicine) reports a rounded subscriber count of 147K. The platform doesn't expose finer-grained numbers, so week-to-week changes below the rounding threshold aren't visible in a chart.
Add to your watchlist to get notified the next time the reported count shifts.
Mental Health Movement by Dr. Jake Goodman
46K subs
Brain Health Kitchen
44K subs
The Metabolic Nutritionist
41K subs
Get email alerts when subscribers drop or spike, when new sponsors appear, when pricing changes, or when publishing cadence shifts. Track unlimited newsletters across your watchlist with the Starter plan.
$29/mo·cancel anytime
See what's includedGet the full whitespace list with each brand's category fit, audience overlap, and recommended pitch order. Plus a comparison of COVID Intel - by William Makis (McGill Medicine) vs the top 15 peer newsletters on sponsor mix, growth, and CPM.
Including Brooklinen, AI technology, Medik8 + 47 more.
$300·2-3 working days·refunded if we can't deliver
Publishing Frequency
Daily
Last published Aug 27, 2026
13.0 posts/week avg
Health Pricing
$6/mo median
Above average(+25%)
Monetization Readiness
Already monetizing
100% of similar-size Health newsletters also have paid tiers
Unlock revenue estimates, CPM benchmarks, and detected sponsors
Start tracking — free147.0K subscribers and 0.13% engagement — past the threshold where Health newsletters typically attract sponsors.
Consistent Publisher
Publishing consistency (96/100) is well above the Health median (67/100).